Work With Us

Target Identification
Combination Therapeutics
Drug Repurposing
Biomarkers
Safety and Toxicity

EVERY DAY, the CytoSolve® Collaboratory™ Integrates Molecular Pathways Derived from In Vitro and In Vivo Scientific Experiments Being Conducted Worldwide

0
Institutions
0
Scientists
0
Experiments

We Provide the 21st Century Platform for Discovery and Development of Therapeutics for Pancreatic Cancer

PancreaSolve

PancreaSolve

PancreaSolve™ provides technology and services towards accelerating drug development using an integrative platform for quantitative modeling of...

Learn more
CytoSolve

CytoSolve

  CytoSolve® is revolutionizing health by accelerating development, discovery and delivery of therapeutics, nutraceuticals and functional...

Learn more
MD Anderson

MD Anderson

  The University of Texas MD Anderson Cancer Center (MDACC) is one of the original three comprehensive cancer centers in the United States...

Learn more
Dr. V.A. Shiva Ayyadurai Delivers State of the Art Lecture at ASCPT Annual Meeting, 2017
Dr. V.A. Shiva Ayyadurai speaks about CytoSolve at FasterCures’ Distinguished Panel on Redefining Discovery for the 21st Century

We Deliver Innovative Solutions

Target Identification

Target Identification

Traditional methods of target discovery have relied on in vitro/ in vivo studies and sometimes molecular dynamics analysis. However, these methods are ad hoc and do...

Read more
Combination Therapeutics

Combination Therapeutics

Recent research has focused on identifying combination of drugs or dietary supplements with maximum effect at minimal dosage levels. However, the in vitro and in vivo...

Read more
Drug Repurposing

Drug Repurposing

Discoveries about the molecular basis of disease provide unprecedented opportunities to find new medicines. Discovery and formulation of new drug takes more than 14...

Read more
Biomarkers

Biomarkers

Mechanistic understanding of complex biological phenomena is needed at a system level to identify novel biomarkers that can be used for better diagnostics of a...

Read more
Safety and Toxicity

Safety and Toxicity

Diverse responses of target or biomarker induced toxicity through different signaling pathways are identified through systematic literature review. Computational...

Read more

Our Scientific Advisory Board

Anirban Maitra
Anirban Maitra
Chairman Scientific Advisory Board; Co-director and Scientific Director, Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Research, MD Anderson
Dr. Anirban Maitra is Professor of Pathology and Translational Molecular Pathology at MD Anderson Cancer Center.
V.A. Shiva Ayyadurai
V.A. Shiva Ayyadurai
Chairman and Chief Executive Officer, CytoSolve, Inc.
Dr. V.A. Shiva Ayyadurai, Ph.D., an MIT systems scientist is the inventor of email and creator of EchoMail. He is also Chairman & CEO of...
Sunil Krishnan
Sunil Krishnan
Director of the Center for Radiation Oncology Research, MD Anderson
Dr. Sunil Krishnan is Professor in the Department of Radiation Oncology, Division of Radiation Oncology at The University of Texas MD Anderson...